Standout Papers

IgG4-Related Disease 2007 2026 2013 2019 1.7k
  1. IgG4-Related Disease (2012)
    John H. Stone, Yoh Zen et al. New England Journal of Medicine
  2. IgG4-related disease (2014)
    Terumi Kamisawa, Yoh Zen et al. The Lancet
  3. IgG4-Related Disease (2013)
    John H. Stone, John K. C. Chan et al. International Journal of Rheumatology
  4. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis (2007)
    Yoh Zen, Takahiko Fujii et al. Hepatology
  5. IgG4-Related Disease (2010)
    Yoh Zen, Yasuni Nakanuma The American Journal of Surgical Pathology
  6. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease (2019)
    Zachary S. Wallace, Ray Naden et al. Annals of the Rheumatic Diseases
  7. IgG4-Related Disease (2015)
    Dai Inoue, Kotaro Yoshida et al. Medicine

Immediate Impact

1 by Nobel laureates 23 from Science/Nature 74 standout
Sub-graph 1 of 20

Citing Papers

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The unique properties of IgG4 and its roles in health and disease
2023 Standout
33 intermediate papers

Works of Yoh Zen being referenced

IgG4-related disease
2014 Standout
Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis
2007 Standout
and 19 more

Author Peers

Author Last Decade Papers Cites
Yoh Zen 10281 8333 3901 8662 349 18.9k
Kazuichi Okazaki 10707 6918 2527 9315 442 16.8k
Yasuni Nakanuma 11591 9193 4874 3188 650 24.4k
Vikram Deshpande 9201 8210 5750 9220 327 20.9k
Thomas C. Smyrk 14557 7043 9507 7896 443 27.7k
Kendo Kiyosawa 5000 9570 1121 5054 362 16.6k
Terumi Kamisawa 11548 6751 4339 8957 315 15.5k
Kenichi Harada 4759 3274 1818 1773 328 9.3k
Lizhi Zhang 4784 3191 2929 3195 182 8.8k
John R. Goldblum 9136 2454 5004 3733 359 20.4k
Shigeyuki Kawa 8176 6167 1109 8991 212 11.4k

All Works

Loading papers...

Rankless by CCL
2026